RSV-related Community COPD Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study.
Dexter J WisemanRyan S ThwaitesAndrew I RitchieLydia FinneyMairi MacleodFaisal KamalHassan ShahbakhtiLisa H van SmoorenburgHuib A KerstjensJoanne WildenbeestDeniz ÖnerJeroen AerssensGuy BerbersRutger ScheppAshley UruchurtuBenedikt DitzLouis BontJames P AllinsonMaarten van den BergeGavin C DonaldsonPeter J M OpenshawJadwiga Wedzichanull nullPublished in: American journal of respiratory and critical care medicine (2024)
RSV is associated with 8.7% of outpatient managed COPD exacerbations in this study. Antibodies to RSV-N protein may have diagnostic value, potentially important in a vaccinated population. The introduction of vaccines that prevent RSV is expected to benefit patients with COPD.